Success Metrics

Clinical Success Rate
96.8%

Based on 150 completed trials

Completion Rate
97%(150/155)
Active Trials
23(11%)
Results Posted
5%(8 trials)
Terminated
5(2%)

Phase Distribution

Ph phase_3
13
6%
Ph phase_4
7
3%
Ph early_phase_1
3
1%
Ph not_applicable
165
76%
Ph phase_1
8
4%
Ph phase_2
22
10%

Phase Distribution

11

Early Stage

22

Mid Stage

20

Late Stage

Phase Distribution218 total trials
Early Phase 1First-in-human
3(1.4%)
Phase 1Safety & dosage
8(3.7%)
Phase 2Efficacy & side effects
22(10.1%)
Phase 3Large-scale testing
13(6.0%)
Phase 4Post-market surveillance
7(3.2%)
N/ANon-phased studies
165(75.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

93.2%

150 of 161 finished

Non-Completion Rate

6.8%

11 ended early

Currently Active

23

trials recruiting

Total Trials

218

all time

Status Distribution
Active(33)
Completed(150)
Terminated(11)
Other(24)

Detailed Status

Completed150
unknown24
Recruiting19
Not yet recruiting9
Withdrawn6
Terminated5

Development Timeline

Analytics

Development Status

Total Trials
218
Active
23
Success Rate
96.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (1.4%)
Phase 18 (3.7%)
Phase 222 (10.1%)
Phase 313 (6.0%)
Phase 47 (3.2%)
N/A165 (75.7%)

Trials by Status

unknown2411%
recruiting199%
withdrawn63%
terminated52%
active_not_recruiting42%
enrolling_by_invitation10%
completed15069%
not_yet_recruiting94%

Recent Activity

Clinical Trials (218)

Showing 20 of 218 trialsScroll for more
NCT04373057Phase 1

Prebiotic Galacto-oligosaccharide and Acute GVHD

Recruiting
NCT05135351Not Applicable

Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy

Recruiting
NCT07537192Not Applicable

Inulin-Spirulina Co-intervention for Insomnia Disorder

Not Yet Recruiting
NCT03667404Phase 2

Resistant Maltodextrin for Gut Microbiome in Parkinson's Disease: Safety and Tolerability Study

Active Not Recruiting
NCT07529457Not Applicable

Akk09 in Adults With Constipation

Not Yet Recruiting
NCT07463092Not Applicable

Creatine Supplementation and Resistance Training to Improve Sarcopenia Parameters in Patients With Prostate Cancer After Androgen Deprivation Therapy

Recruiting
NCT07507955Not Applicable

Probiotics for Constipation Relief in Adults

Not Yet Recruiting
NCT07502404Not Applicable

Lactobacillus Gasseri and Hormonal Regulation in Obese Women

Completed
NCT07499414Not Applicable

The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease.

Recruiting
NCT05416229Phase 2

Psilocybin-assisted Therapy for Treatment of Alcohol Use Disorder

Completed
NCT06440252Phase 3

Effectiveness of a Grape Seed Extract on Circulatory Measures in Healthy Adults

Completed
NCT06444763Phase 3

Effect of Maolactin™ FMR on Exercise Recovery, Inflammation and Muscle Comfort in an Otherwise Healthy Population

Completed
NCT05540132Not Applicable

Slow Digestible Carbohydrates and Exercise in Adolescents With Type 1 Diabetes

Withdrawn
NCT05632341Not Applicable

GCWB1176 Evaluates the Effectiveness and Safety of Immune Function

Completed
NCT05544942Not Applicable

GCWB1001 Evaluates the Effectiveness and Safety of Respiratory Health

Completed
NCT06852365Phase 2

Combined Oral Contraceptive Pill and Resistance Starch

Recruiting
NCT05906589Not Applicable

Exploring Mechanism of Action of Dietary Fibre on the Gut Microbiota and Metabolites

Completed
NCT06027242Not Applicable

Oral Supplementation of Glutamine on Gastric Cancer Patients After Gastrectomy

Recruiting
NCT05485402Not Applicable

Dietary Strategy to Tackle Sarcopenia in Early Elderly Subjects (FOOP-Sarc)

Completed
NCT04543877Early Phase 1

WHNRC (Western Human Nutrition Research Center) Fiber Intervention Study

Completed

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
218